ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985